This team noted that CEACAM6 gene silencing reduces the metastatic ability of pancreatic adenocarcinoma cells by impairing anoikis resistance in PDAC cell lines and tested it with a nude mouse orthotopic xenograft model [25]. This evidence concerns the gene CEACAM6 and pancreatic adenocarcinoma.